The Renuvion® device does not rely on full-thickness heating to achieve the desired coagulation effect. This reduces the time needed for the energy application and allows for a more time-efficient procedure. In a preclinical study where the helium plasma energy was applied at a maximum of six passes at 80% power, surface skin temperature was shown to reach a maximum of 40°C – an increase of just 1.5°C.1
This thermal image and photo were taken during a subdermal arm procedure of a 51-year-old female. These pictures show a minimal rise in surface temperatures during the application of the energy.
One of the most exciting advancements in energy technology in the past 20 years, The Renuvion system combines the unique properties of cold helium plasma with the efficiency of RF energy. This synergy enables a high degree of precision, and always with minimal thermal effect to surrounding tissue.
Renuvion has FDA clearance for the cutting, coagulation and ablation of soft tissue during open and laparoscopic surgical procedures.2
- A Study Evaluating The Effects of J-Plasma on Porcine Skin Tissue During Subdermal Application. Bovie® Study VR-1597, 8/2017.
- Renuvion/J-Plasma has received a general clearance and has not been determined to be safe or effective for use in any specific procedures for the treatment of any specific conditions.